[Retracted] AIM2 Promotes Gastric Cancer Cell Proliferation via the MAPK Signaling Pathway

Figure 1

AIM2 is upregulated in gastric cancer. ( < 0.05, Data obtained from three independent are represented as means and standard errors.) (a) AIM2 expression in GC tumor (n = 375) and paracancerous normal control tissues (n = 32) was assessed. (b) AIM2 expression was quantified in pairs of GC tumors and control tissues. (c) Assessment of AIM2 ROC curve sensitivity and specificity. (d) Western blotting was used to assess AIM2 protein levels in matched tumor (T) and normal (N) tissue samples. AIM2 is upregulated in GC cell lines.

(a)

(b)

(c)

(d)